SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?


To: AHM who wrote (686)7/1/1998 9:18:00 AM
From: Robert Knight  Respond to of 1510
 
I believe we have said the same thing....

I have said in prior posts that there has not been anyone supporting the bid. Meanwhile sellers, whether short or real, have been proactive in leaning on the stock from the offer. Your point is accurate. I believe my point is as well. NITE is a notorious short side player. Good luck....

Robert



To: AHM who wrote (686)7/1/1998 9:26:00 AM
From: Robert Knight  Respond to of 1510
 
Interesting post from Yahoo....

messages.yahoo.com@m2.yahoo.com



To: AHM who wrote (686)7/1/1998 10:07:00 AM
From: AHM  Read Replies (1) | Respond to of 1510
 
It is anticipated that Dr. Valentine's presentation on Friday will disclose that results from REMUNE tests are the best ever seen from any treatment to date. If true, IMNR could soar on Monday. Those who are complaining about present market levels have a splendid opportunity to add IMNR to their portfolios if they agree with this speculation.